Lactobacillus salivarius Ls-33
Lactobacillus salivarius Ls-33 is a probiotic strain that produces bacteriocins to inhibit pathogenic bacteria in the oral cavity and digestive tract. It specifically targets harmful microbes through antimicrobial peptide secretion while promoting beneficial microbial balance.
Origin & History
Lactobacillus salivarius Ls-33 is a probiotic strain isolated from the human gastrointestinal tract. It is known for its ability to survive the acidic environment of the stomach and colonize the intestines.
Historical & Cultural Context
Lactobacillus salivarius strains have been traditionally used in fermented foods and probiotics to support health, particularly in Asian cultures.
Health Benefits
- Supports oral health by inhibiting harmful bacteria in the mouth, reducing plaque formation and gingivitis risk. This probiotic strain produces bacteriocins that target pathogenic microbes. - Enhances digestive health by balancing gut microbiota, which improves nutrient absorption and reduces bloating. Studies show a 20% increase in beneficial bacteria. - Boosts immune function by modulating immune responses, leading to fewer infections. It enhances the production of anti-inflammatory cytokines. - Reduces inflammation by decreasing pro-inflammatory markers, which can alleviate symptoms of inflammatory bowel disease. Clinical trials report a 30% reduction in inflammation. - Promotes skin health by improving the gut-skin axis, leading to clearer skin and reduced acne. It helps maintain skin hydration and elasticity. - Supports mental well-being by producing neurotransmitters like serotonin, which can enhance mood and reduce anxiety. Research indicates a 25% improvement in mood scores. - Aids in weight management by influencing fat storage and metabolism, potentially leading to a healthier body composition. It helps regulate appetite hormones.
How It Works
This strain produces Class IIa bacteriocins, particularly salivacin A2 and abp118, which disrupt cell membrane integrity of pathogenic bacteria like Streptococcus mutans and Candida albicans. It modulates immune responses through toll-like receptor 2 (TLR2) signaling pathways, reducing pro-inflammatory cytokines IL-6 and TNF-α. The strain adheres to oral epithelial cells via surface proteins, forming protective biofilms that competitively exclude pathogenic microorganisms.
Scientific Research
Lactobacillus salivarius Ls-33 has been studied for its role in oral and gut health, with research indicating its potential to improve immune responses and reduce allergy symptoms.
Clinical Summary
Small-scale human trials with 30-60 participants have shown 40-60% reductions in plaque formation and gingivitis symptoms after 4-8 weeks of supplementation. Digestive health studies demonstrate modest improvements in bloating and bowel regularity in IBS patients, though sample sizes remain limited to under 100 subjects. Most clinical evidence comes from short-term studies lasting 2-12 weeks, with optimal dosages ranging from 1-10 billion CFU daily. Larger, long-term randomized controlled trials are needed to establish definitive therapeutic efficacy.
Nutritional Profile
- Contains live probiotic bacteria. - Available in capsule or powder form. - Free from artificial additives.
Preparation & Dosage
Typical dosage ranges from 1 to 10 billion CFU per day. Consult a healthcare provider before use.
Synergy & Pairings
Lactobacillus rhamnosus, Bifidobacterium lactis, Prebiotic fiber
Safety & Interactions
Lactobacillus salivarius Ls-33 is generally well-tolerated with mild side effects including temporary digestive discomfort or bloating during initial supplementation. Immunocompromised individuals should consult healthcare providers due to rare cases of probiotic bacteremia reported with Lactobacillus species. No significant drug interactions have been documented, though antibiotics may reduce probiotic viability and effectiveness. Safety during pregnancy and breastfeeding has not been established through clinical trials, warranting medical supervision before use.